Ranibizumab Biosimilar - Resea

Ranibizumab Biosimilar - Research Grade. Clonality: Recombinant. Host: Humanized. Reactivity: Human. Form: Liquid. Purity: >95% by SDS-PAGE and HPLC. Storage: Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.. This is an unconjugated, non-therapeutic recombinant analog of ranibizumab, an anti-VEGF-A biologic, supplied strictly for research use only. It is built to recognise human vascular endothelial growth factor A (VEGF-A, UniProt P15692) and reproduces the target-binding behaviour of the originator so investigators can use it as a defined reference reagent rather than as a clinical product. Note that clinical ranibizumab is an antigen-binding fragment (Fab) rather than a full antibody; this researc